QUOTE AND NEWS
StreetInsider.com  Mar 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/SIGA+Technologies%2C+Inc.+%28SIGA%29+Tops+Q4+EPS+by+1c/8162923.html for the full story.
StreetInsider.com  Nov 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/SIGA+Technologies%2C+Inc.+%28SIGA%29+Misses+Q3+EPS+by+17c/7845389.html for the full story.
StreetInsider.com  Jun 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/SIGA+Tech+%28SIGA%29+Files+Notice+of+Appeal+in+Delaware+to+Overturn+PharmAthene+Order/7512179.html for the full story.
Globe Newswire  Jun 4  Comment 
NEW YORK, June 4, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons, announced today that it had appointed William J.
Benzinga  Jun 2  Comment 
Below are highlights from Benzinga's daily coverage of microcap securities making big moves: PharmAthene Shares of PharmAthene (NYSE: PIP), the Annapolis, MD biodefense company, rose 27.87% Friday on 13 times the average daily...
Globe Newswire  Jun 1  Comment 
NEW YORK, June 1, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons, today reported that the Delaware Chancery Court has
Globe Newswire  May 7  Comment 
NEW YORK, May 7, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons, today reported its financial results for the quarter
Globe Newswire  Apr 30  Comment 
NEW YORK, April 30, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight lethal disease causing pathogens, announced today that management will host a conference
StreetInsider.com  Mar 26  Comment 
SIGA Tech (Nasdaq: SIGA) 31.7% HIGHER; seems to be breaking above the 200-day SMA after holding closely to this technical indicator for the last week or two. Volume is very heavy today and increased further as the stock pushed over the $3...
Globe Newswire  Mar 1  Comment 
NEW YORK, New York, March 1, 2012 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons, today reported its financial results for





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki